The University of Edinburgh
Vasoactive hormone studies in man using urotensin II and vasopressin
Abstract
dc:description.abstractBACKGROUND Within this thesis we have examined the effects on vascular tone of two peptide hormones, urotensin II and vasopressin. Human urotensin II is a novel vasoactive peptide hormone with receptors located on human arterial tissue and ventricular myocytes. It is the most potent arterial vasoconstrictor yet discovered and has a sustained effect on blood vessels from a variety of species with potency 28 to 50 fold greater than endothelin-1. Vasopressin has however, been known to have arterial vasoconstrictor properties in man in vivo for many years. However, peptide antagonists for the VI receptor, mediating vasoconstriction, and the V2 receptor, mediating vasodilatation, have often been of poor selectivity and subject to inter-species variation, thus clouding the true arterial pharmacodynamic effects of vasopressin. Two novel peptidic arginine vasopressin antagonists have recently been produced and offer potentially more receptor selectivity
Degree
thesis:*- Grantor dc:publisher
- The University of Edinburgh
- Year dc:date.issued
- 2007
Author and committee
dc:creator, dc:contributor.*- Author dc:creator
-
- Affolter, Jonathan Theodore
Identifiers
dc:identifier.*- Handle dc:identifier.uri
- http://hdl.handle.net/1842/28010